Chemoinformaics analysis of 9H-Xanthen-9-one, 2-hydroxy-3-methoxy-
| Molecular Weight | 242.23 | nRot | 1 |
| Heavy Atom Molecular Weight | 232.15 | nRig | 17 |
| Exact Molecular Weight | 242.058 | nRing | 3 |
| Solubility: LogS | -3.635 | nHRing | 1 |
| Solubility: LogP | 2.885 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 16 |
| nHA | 4 | APOL | 33.2559 |
| nHD | 1 | BPOL | 14.3721 |
| QED | 0.666 |
| Synth | 1.96 |
| Natural Product Likeliness | 0.712 |
| NR-PPAR-gamma | 0.101 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.951 |
| HIA | 0.005 |
| CACO-2 | -4.809 |
| MDCK | 0.0000204 |
| BBB | 0.166 |
| PPB | 0.906437 |
| VDSS | 0.605 |
| FU | 0.114461 |
| CYP1A2-inh | 0.965 |
| CYP1A2-sub | 0.947 |
| CYP2c19-inh | 0.678 |
| CYP2c19-sub | 0.251 |
| CYP2c9-inh | 0.525 |
| CYP2c9-sub | 0.89 |
| CYP2d6-inh | 0.554 |
| CYP2d6-sub | 0.888 |
| CYP3a4-inh | 0.359 |
| CYP3a4-sub | 0.274 |
| CL | 3.925 |
| T12 | 0.653 |
| hERG | 0.059 |
| Ames | 0.78 |
| ROA | 0.194 |
| SkinSen | 0.919 |
| Carcinogencity | 0.735 |
| EI | 0.977 |
| Respiratory | 0.405 |
| NR-Aromatase | 0.692 |
| Antiviral | Yes |
| Prediction | 0.624294 |